Back to School: How biopharma can reboot drug development. Access exclusive analysis here

EMD 121974: Began Phase I testing

Merck KGaA, Darmstadt, Germany
Product: EMD 121974
Business:

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE